Aarti Pharmalabs Ltd - Stock Valuation and Financial Performance

BSE: 543748 | NSE: AARTIPHARM | Pharmaceuticals & Drugs | Small Cap

Aarti Pharmalabs Share Price

435 -0.15 -0.03%
as on 28-Mar'24 15:30

DeciZen - make an informed investing decision on Aarti Pharmalabs

Overall Rating
Bole Toh

1. Quality

2. Valuation

Overvalued

3. Price Trend

Aarti Pharmalabs stock performance -

mw4me loader
P/E Ratio (SA):
22.20
Market Cap:
3,943.6 Cr.
52-wk low:
269
52-wk high:
594.9

Is Aarti Pharmalabs Ltd an attractive stock to invest in?

1. Is Aarti Pharmalabs Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Aarti Pharmalabs Ltd is a below average quality company.

2. Is Aarti Pharmalabs Ltd undervalued or overvalued?

The key valuation ratios of Aarti Pharmalabs Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Aarti Pharmalabs Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Aarti Pharmalabs Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Aarti Pharmalabs:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Aarti Pharmalabs Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % 0%0%0%0%0%0%-8.1%-1.9%14.3%11.5%-
Value Creation
Index
NANANANANANA-1.6-1.10.0-0.2-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 000000009411,5111,462
Sales YoY Gr.-NANANANANANANANA60.6%-
Adj EPS 000000-0.8-0.24,268.21919.6
YoY Gr.-NANANANANANANANA-99.6%-
BVPS (₹) 0000009.39.149,558.5158.7174
Adj Net
Profit
00000000107172178
Cash Flow from Ops. 00000000-64.8229-
Debt/CF from Ops. 00000000-50.9-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANANA60.6%
Adj EPS NANANA-99.6%
BVPSNANA157.9%-99.7%
Share Price - - - 56.2%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
000000-8.1-216.612.611.8
Op. Profit
Mgn %
0000000019.120.421.6
Net Profit
Mgn %
0000000011.311.412.2
Debt to
Equity
00000000.10.30.1-
Working Cap
Days
00000000163217121
Cash Conv.
Cycle
0000000011614964

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 11.80%

Sales growth has been subdued in last 3 years 0.00%

Net Profit has been subdued in last 3 years 0.00%

Sales growth is not so good in last 4 quarters at -2.39%

Latest Financials - Aarti Pharmalabs Ltd.

Standalone Consolidated
TTM EPS (₹) 19.6 21.5
TTM Sales (₹ Cr.) 1,462 1,832
BVPS (₹.) 174 188.7
Reserves (₹ Cr.) 1,531 1,665
P/BV 2.50 2.31
PE 22.20 20.27
From the Market
52 Week Low / High (₹) 269.00 / 594.90
All Time Low / High (₹) 269.00 / 594.90
Market Cap (₹ Cr.) 3,944
Equity (₹ Cr.) 45.3
Face Value (₹) 5
Industry PE 47.8

Management X-Ray of Aarti Pharmalabs:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Aarti Pharmalabs

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'20Mar'21Mar'22Mar'23
Sales009411,511
Operating Expenses 007611,203
Manufacturing Costs00202333
Material Costs00452701
Employee Cost 0080122
Other Costs 002747
Operating Profit 00180308
Operating Profit Margin (%) --19.1%20.4%
Other Income 0031
Interest 001120
Depreciation 003756
Exceptional Items 0000
Profit Before Tax 00134233
Tax 002762
Profit After Tax 00107172
PAT Margin (%) --11.3%11.4%
Adjusted EPS (₹)-0.8-0.24,269.119.0
Dividend Payout Ratio (%)0%0%0%11%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 001,2391,439
Share Capital 00045
Reserves 001,2391,393
Minority Interest0000
Debt00325207
Long Term Debt0000
Short Term Debt00325207
Trade Payables00132220
Others Liabilities 0013298
Total Liabilities 001,8271,963

Fixed Assets

Gross Block001,1011,304
Accumulated Depreciation00400455
Net Fixed Assets00701848
CWIP 00187102
Investments 004043
Inventories00444538
Trade Receivables00304362
Cash Equivalents 005613
Others Assets009358
Total Assets 001,8271,963

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity 00-65229
PBT 00134233
Adjustment 004675
Changes in Working Capital 00-230-23
Tax Paid 00-15-57
Cash Flow From Investing Activity 00-134-116
Capex 00-136-116
Net Investments 0000
Others 0021
Cash Flow From Financing Activity 00255-157
Net Proceeds from Shares 0000
Net Proceeds from Borrowing 0000
Interest Paid 00-11-20
Dividend Paid 000-18
Others 00266-118
Net Cash Flow 0056-43
PARTICULARSMar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)-8.07-217.2312.83
ROCE (%)-8.07-1.9318.0315.6
Asset Turnover Ratio001.030.8
PAT to CFO Conversion(x)NANNAN-0.611.33
Working Capital Days
Receivable Days0011880
Inventory Days00172119
Payable Days005392

Aarti Pharmalabs Ltd Stock News

Aarti Pharmalabs Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Aarti Pharmalabs on 28-Mar-2024 15:30 is ₹435.0.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 28-Mar-2024 15:30 the market cap of Aarti Pharmalabs stood at ₹3,943.6.
The latest P/E ratio of Aarti Pharmalabs as of 28-Mar-2024 15:30 is 22.20.
The latest P/B ratio of Aarti Pharmalabs as of 28-Mar-2024 15:30 is 2.50.
The 52-week high of Aarti Pharmalabs is ₹594.9 and the 52-week low is ₹269.0.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Aarti Pharmalabs is ₹1,462 ( Cr.) .

About Aarti Pharmalabs Ltd

Aarti Pharmalabs Limited (APL) (Formerly known as Aarti Organics Limited) is a leading Indian manufacturer of Pharmaceuticals and Nutraceuticals with a global footprint.

Over the past two decades, enabled by cutting-edge R&D and manufacturing capabilities APL has evolved as a reliable partner of choice for generic players and innovators across the globe. The company specialises in generic APIs, generic intermediates, and xanthine derivatives. It delivers CDMO services for drug substance/NCE development and manufacturing for innovative pharmaceutical and biotech firms with a focus on the Ph-I/II/III, launch, and commercial phases. It has dedicated facilities for the production of HPAPIs, corticosteroids, cytotoxic medicines, and oncology products.

With the biggest manufacturing capacity in India for its flagship product ‘Caffeine’ APL has emerged as a preferred partner for the Beverages, Nutraceuticals manufacturing companies, and Pharmaceuticals Industries across the world.

Business area of the company

The company is an, internationally recognised manufacturer of Active Pharmaceutical Ingredients (API), pharmaceutical intermediates, New Chemical Entities (NCE), and xanthine derivatives situated in India. In order to build a sustainable future, it integrates process chemistry proficiency (recipe focus) with scale-up engineering proficiency (asset utilisation).

Products and services

  • API
  • Intermediates
  • CDMO Services
  • Caffeine
  • Xanthine Derivatives
  • Acid & Allied

Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.